Patents for A61P 23 - Anaesthetics (4,141)
01/2006
01/12/2006US20060009375 Site-specific drug delivery
01/12/2006US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation
01/11/2006CN1720031A Propofol-containing fat emulsions
01/04/2006EP1612273A1 Novel physiologically active substances pf1270a, b and c
01/04/2006EP1610742A2 Methods and compositions for administration of trpv1 agonists
01/04/2006CN1717229A Composition and its use for treating neuropathic sensory loss
01/04/2006CN1714867A Triacetin as a transdermal penetration enhancer
12/2005
12/29/2005WO2005123728A1 Novel 9-aza-bicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/28/2005EP1608381A2 Novel therapeutic application for a composition
12/27/2005CA2252050C Buccal, non-polar spray or capsule
12/22/2005DE102004027685A1 Method and composition useful e.g. to improve the symptoms of hypersensitive teeth or toothache comprises applying topical formulation comprising sodium-channel blockers (e.g. tetracaine or bupivacaine) and additives on the tooth surface
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/14/2005EP1604652A2 Topical anaesthetic preparation for pretreatment for upper gastrointestinal endoscopy
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/08/2005US20050271713 Topical anesthetic preparation for pretreatment for upper gastrointestinal endoscopy
12/07/2005CA2509183A1 Topical anesthetic preparation for pretreatment for upper gastrointestinal endoscopy
11/2005
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/16/2005EP1594859A1 Indazolamides with analgesic activity
11/16/2005EP0766538B1 Subcutaneous implant
11/16/2005CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/09/2005EP1418891B1 Anaesthetic formulations of propofol
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/08/2005US6962976 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole
11/03/2005WO2005102365A1 Neurotransmission switching material
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
10/2005
10/27/2005US20050239831 Bupivacaines
10/27/2005US20050239746 Pharmaceutical composition
10/26/2005EP1265618B1 Anaesthetic compositions comprising alfaxalone
10/26/2005EP1073415B1 Pharmaceutical compositions capable of being gelled
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/19/2005EP1586347A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/19/2005EP1585519A1 High concentration formulations of opioids and opioid derivatives
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956055 Substituted γ-lactone compounds as NMDA-antagonists
10/13/2005US20050228336 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/13/2005US20050228022 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/07/2005CA2504404A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/06/2005US20050222260 (2S)-2-amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
10/05/2005EP1582220A1 Composition for topical anesthesia
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221249C Injectable aqueous dispersions of propofol
09/2005
09/29/2005US20050215633 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means
09/21/2005EP1576953A1 Propofol-containing fat emulsions
09/21/2005CN1671395A Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
09/21/2005CN1671387A Aryl substituted hydantoin compounds and their use as sodium channel blockers
09/21/2005CN1671367A Aqueous 2, 6-diisopropylphenol pharmaceutical compositions
09/15/2005WO2005032521A3 Non-flammable topical anesthetic liquid aerosols
09/15/2005WO2004103260A3 Ternary and quaternary eutectic mixtures.
09/15/2005US20050203068 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/14/2005CN1668316A Anti-spasmodic comprising xenon
09/13/2005CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/07/2005EP1571140A1 C-substituted cyclohexylmethylamine derivatives
09/07/2005EP1140016B1 Composition set and kit for use in intraocular surgery
09/07/2005CN1665484A Warming and nonirritating lubricant compositions and method of comparing irritation
09/07/2005CN1217918C Aminocyclohexyl ether compounds and uses thereof
09/07/2005CN1217661C Choline antagonist sticking preparation
09/01/2005US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
08/2005
08/31/2005CN1660094A Ropivacaine hydrochloride in use for injection and preparation technique
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936605 Pharmaceutical composition
08/25/2005US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis
08/25/2005US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability;
08/24/2005EP1566378A1 Isoindoline derivative
08/24/2005EP1565173A2 Composition and its use for treating neuropathic sensory loss
08/24/2005EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
08/24/2005EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
08/18/2005US20050180926 Inhalable aerosol medicament for the treatment or prevention of pain
08/17/2005EP1563839A1 A method of analgesia
08/17/2005EP1562581A2 Pharmaceutical composition comprising cannabinoids for the treatment of pain andsleep disorders
08/16/2005US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders
08/16/2005US6929805 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA)
08/10/2005CN1213733C Method of preparing stable suspension of insoluble microparticles
08/04/2005WO2005030700A3 Amino acids with affinity for the alpha2delta-protein
08/04/2005US20050171074 3 alpha-hydroxy-3 beta-methoxymethyl-substituted steroids and the use thereof
08/03/2005EP1558227A1 Injectable 2,6-diisopropylphenol-containing anesthetic composition and methods
08/03/2005EP0998288B2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
08/03/2005CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
08/03/2005CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones
08/03/2005CN1212809C Subcutaneous implant
08/02/2005US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases
07/2005
07/28/2005US20050165098 Local anesthetic methods and kits
07/28/2005US20050165097 Comprising a local anesthetic, an alpha adrenergic receptor agonist and a low dose of an alpha adrenergic receptor antagonist, for reversing local anesthesia
07/28/2005US20050163859 Injectable compositions for the controlled delivery of pharmacologically active compound
07/28/2005US20050163719 Buccal, polar and non-polar spray containing diazepam
07/27/2005EP1556002A2 Implantable structure for prolonged and controlled release of an active principle
07/27/2005EP1555976A2 Propofol with cysteine
07/27/2005EP1124537B1 Propofol composition
07/27/2005EP1107733B1 Oral liquid mucoadhesive compositions
07/27/2005CN1646500A Aryl substituted pyrimidines and the use thereof
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 42